Topics

Global Ureteral Stents Market to Surpass US$ 564.4 Million By 2026

09:34 EDT 10 Jul 2019 | Businesswire
Coherent Market Insights

According to Coherent Market Insights, the global ureteral stents market was valued at US$ 359.9 million in 2018, and is projected to exhibit a CAGR of 5.8% during the forecast period (2018 – 2026).

Key Trends and Analysis of the global Ureteral Stents Market:

Presence of key players who are focused on developing products that can bypass limitations such as infection, discomfort, and other problems, is contributing significantly to the market growth. For instance, in January 2019, Q Urological Corporation developed an aqueous hydrogel biomaterial, pAguamedicina, and patented processing method for production of very high aqueous content to produce 100% hydrogel catheters and stents.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2172

In addition, technological innovation in urology products are providing an immense opportunity for the manufacturer to produce technologically advanced ureteral stents. For instance, in June 2018, HydrUStent has developed the Hydrustent Biodegradable Ureteral Stent from its patented material, which prevents the need for a second surgery for stent removal, and also prevents bacterial colonization and biofilm formation which leads to infection.

Moreover, increasing prevalence of urological and kidney related disorders is expected to lead to high demand for ureteral stents over the forecast period. For instance, according to the National Center for Biotechnology Information (NCBI), October 2018, an estimated 1 to 19% of the population in India is suffering from urolithiasis.

Furthermore, increasing demand for kidney transplant procedures is expected to contribute to the market value. For instance, according to the Global Observatory on Donation and Transplantation, 2016, around 89,823 kidney transplant surgeries were performed worldwide in 2016, which was an increase by 6.5% from 2015. Thus, the increasing number of renal transplants and growing concerns related to urological dysfunctioning has increased demand for ureteral stents for post-operative convenience.

Acquisitions by key players in order to enhance their product portfolios is also facilitating growth of the global ureteral stents market. For instance, in June 2019, Merit Medical Systems, Inc. acquired Brightwater Medical, Inc., to align Merit’s Resolve drainage catheter portfolio with the Brightwater’s ConvertX biliary stent system, and enhance the company’s sales outside the U.S.

Inquire before Buying this Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2172

Key Market Takeaways:

  • The global ureteral stents market is projected to witness a CAGR of 5.8% during the forecast period (2018 – 2026) owing to increasing regulatory approvals for ureteral stents. For instance, in 2017, Q Urological Corporation received the U.S. Food and Drug Administration (FDA) approval for its new AguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent. In 2018, the company announced the first human placement of its AguaMedicina PERSISTENT Structural Hydrogel Ureteral Stent.
  • Among region, North America is expected to be the most lucrative region in the ureteral stents market, owing to high diagnosis and treatment rate of urological and kidney related disorders, increasing healthcare expenditure, high awareness for healthcare and access of ureteral stents due to presence of major players in the region
  • Major players operating in the global ureteral Stents market include HydrUStent, LDA, UROMED Kurt Drews KG, Taewoong Medical Co., Ltd., Pnn Medical A/S, Optimed Medizinische Instrumente GmbH, Applied Medical Resources Corporation, Allium Medical Solutions Ltd., Cook Group, Becton, Dickinson And Company, B. Braun Melsungen AG, Coloplast A/S, Q Urological Corporation, Boston Scientific Corporation, Olympus Corporation, and Teleflex Incorporated.

Report Segmentation:

Global Ureteral Stents Market, By Product Type

  • Double Pigtail Stents
  • Multiloop Stents

Global Ureteral Stents Market, By Product Type

  • Metal Stents
  • Polymer Stents
    • Silicone Ureteral Stents
    • Hybrid Ureteral Stents
    • Polyurethane Ureteral Stents

Global Ureteral Stents Market, By Application

  • Kidney Stones
    • Ureteroscopy
    • Lithotripsy
    • Percutaneous Nephrolithotomy
  • Kidney Transplantation
  • Urinary Incontinence
  • Tumors
  • Others

Global Ureteral Stents Market, By End User:

  • Hospitals
  • Gastrointestinal Surgery Clinics
  • Ambulatory Surgical Centers

Global Ureteral Stents Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa

Company Profiles

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/ureteral-stents-market-2172

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

NEXT ARTICLE

More From BioPortfolio on "Global Ureteral Stents Market to Surpass US$ 564.4 Million By 2026"

Quick Search

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Biomaterial
A biomaterial is defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic proc...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...